Soc. Generale Bonus Zert MRK 28.0.../ DE000SV4G2Z5 /
5/24/2024 9:41:16 PM | Chg.+0.010 | Bid5/24/2024 | Ask5/24/2024 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
189.120EUR | +0.01% | 189.120 Bid Size: 500 |
189.800 Ask Size: 500 |
MERCK KGAA O.N. | - EUR | 6/28/2024 | Call |
GlobeNewswire
5/24
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenaden...
GlobeNewswire
5/7
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
5/6
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA